ClearPoint Neuro, Inc. (CLPT)
13.96
-0.09
(-0.64%)
USD |
NASDAQ |
Sep 04, 16:00
14.00
+0.04
(+0.29%)
After-Hours: 20:00
ClearPoint Neuro Total Liabilities (Quarterly) : 75.96M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.96M |
| March 31, 2026 | 74.58M |
| December 31, 2025 | 72.87M |
| September 30, 2025 | 44.48M |
| June 30, 2025 | 43.13M |
| March 31, 2025 | 10.08M |
| December 31, 2024 | 13.80M |
| September 30, 2024 | 11.19M |
| June 30, 2024 | 20.44M |
| March 31, 2024 | 19.05M |
| December 31, 2023 | 21.49M |
| September 30, 2023 | 19.74M |
| June 30, 2023 | 20.23M |
| March 31, 2023 | 17.67M |
| December 31, 2022 | 18.60M |
| September 30, 2022 | 17.86M |
| June 30, 2022 | 17.42M |
| March 31, 2022 | 16.04M |
| December 31, 2021 | 16.79M |
| September 30, 2021 | 24.58M |
| June 30, 2021 | 24.36M |
| March 31, 2021 | 30.28M |
| December 31, 2020 | 27.14M |
| September 30, 2020 | 21.70M |
| June 30, 2020 | 21.69M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.83M |
| December 31, 2019 | 7.340M |
| September 30, 2019 | 7.381M |
| June 30, 2019 | 6.362M |
| March 31, 2019 | 7.183M |
| December 31, 2018 | 6.346M |
| September 30, 2018 | 6.186M |
| June 30, 2018 | 8.029M |
| March 31, 2018 | 7.599M |
| December 31, 2017 | 8.069M |
| September 30, 2017 | 8.179M |
| June 30, 2017 | 8.324M |
| March 31, 2017 | 8.396M |
| December 31, 2016 | 8.157M |
| September 30, 2016 | 8.440M |
| June 30, 2016 | 10.41M |
| March 31, 2016 | 11.91M |
| December 31, 2015 | 12.08M |
| September 30, 2015 | 12.10M |
| June 30, 2015 | 13.74M |
| March 31, 2015 | 14.38M |
| December 31, 2014 | 13.49M |
| September 30, 2014 | 14.43M |
| June 30, 2014 | 12.99M |
| March 31, 2014 | 13.19M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| SINTX Technologies, Inc. | 5.60M |
| Penumbra, Inc. | 443.96M |
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 86.74M |
| Shareholders Equity (Quarterly) | 10.78M |
| Debt to Equity Ratio | 5.934 |
| Current Ratio | 4.725 |
| Net Debt Paydown Yield | -2.22% |